Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.

Saved in:
Bibliographic Details
Title: Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Authors: Vaishnavi A; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Juan J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Jacob M; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Stehn C; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Gardner EE; Meyer Cancer Center, Weill Cornell Medicine, New York City, New York.; Palo Alto Wellness, Menlo Park, California., Scherzer MT; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Department of Oncological Sciences, University of Utah, Salt Lake City, Utah., Schuman S; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Van Veen JE; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Murphy B; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Hackett CS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Dupuy AJ; Department of Anatomy and Cell Biology, University of Iowa, Iowa City, Iowa., Chmura SA; Meyer Cancer Center, Weill Cornell Medicine, New York City, New York.; Palo Alto Wellness, Menlo Park, California., van der Weyden L; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom., Newberg JY; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida., Liu A; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Mann K; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida., Rust AG; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom., Weiss WA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.; Department of Neurology, University of California, San Francisco, California.; Department of Dermatology, University of Utah, Salt Lake City, Utah.; Department of Pediatrics, University of California, San Francisco, California.; Department of Neurological Surgery, University of California, San Francisco, California., Kinsey CG; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Department of Internal Medicine, University of Utah, Salt Lake City, Utah., Adams DJ; Department of Dermatology, University of Utah, Salt Lake City, Utah.; Department of Pediatrics, University of California, San Francisco, California., Grossmann A; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Department of Pathology, University of Utah, Salt Lake City, Utah., Mann MB; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida., McMahon M; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.; Department of Oncological Sciences, University of Utah, Salt Lake City, Utah.; Department of Dermatology, University of Utah, Salt Lake City, Utah.; Department of Pediatrics, University of California, San Francisco, California.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California.
Source: Cancer research [Cancer Res] 2022 Nov 15; Vol. 82 (22), pp. 4261-4273.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-21-3214